South & Central America Infectious Disease Diagnostics Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. South & Central America Infectious Disease Diagnostics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. South & Central America Infectious Disease Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Prevalence of infectious diseases
5.1.2 Need for early and accurate diagnosis

5.2 Market Opportunities

5.2.1 Government initiatives for disease control
5.2.2 Expansion in remote testing services

5.3 Future Trends

5.3.1 Point-of-care testing
5.3.2 Molecular diagnostics advancements

5.4 Impact of Drivers and Restraints

6. South & Central America Infectious Disease Diagnostics Market Regional Analysis

6.1 South & Central America Infectious Disease Diagnostics Market Overview

6.2 South & Central America Infectious Disease Diagnostics Market Revenue 2020-2030 (US$ Million)

6.3 South & Central America Infectious Disease Diagnostics Market Forecast Analysis

7. South & Central America Infectious Disease Diagnostics Market Analysis – by Product

7.1 Kits & Reagents

7.1.1 Overview
7.1.2 Kits & Reagents: South & Central America Infectious Disease Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Instruments

7.2.1 Overview
7.2.2 Instruments: South & Central America Infectious Disease Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Software & Services

7.3.1 Overview
7.3.2 Software & Services: South & Central America Infectious Disease Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Infectious Disease Diagnostics Market Analysis – by Technology

8.1 Biosensor-Based

8.1.1 Overview
8.1.2 Biosensor-Based: South & Central America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Immunodiagnostics

8.2.1 Overview
8.2.2 Immunodiagnostics: South & Central America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Molecular-Based Diagnostic Techniques

8.3.1 Overview
8.3.2 Molecular-Based Diagnostic Techniques: South & Central America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.4 Clinical Biology

8.4.1 Overview
8.4.2 Clinical Biology: South & Central America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Infectious Disease Diagnostics Market Analysis – by Application Type

9.1 Laboratory Testing and Point-of-Care Testing

9.1.1 Overview
9.1.2 Clinical Biology: South & Central America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Infectious Disease Diagnostics Market – South and Central America Analysis

10.1 South and Central America

10.1.1 South & Central America Infectious Disease Diagnostics Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 South & Central America Infectious Disease Diagnostics Market – Revenue and Forecast Analysis – by Country
10.1.1.1 Brazil: South & Central America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 Brazil: South & Central America Infectious Disease Diagnostics Market Breakdown, by Product
10.1.1.1.2 Brazil: South & Central America Infectious Disease Diagnostics Market Breakdown, by Technology
10.1.1.1.3 Brazil: South & Central America Infectious Disease Diagnostics Market Breakdown, by Application Type

10.1.1.2 Argentina: South & Central America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Argentina: South & Central America Infectious Disease Diagnostics Market Breakdown, by Product
10.1.1.2.2 Argentina: South & Central America Infectious Disease Diagnostics Market Breakdown, by Technology
10.1.1.2.3 Argentina: South & Central America Infectious Disease Diagnostics Market Breakdown, by Application Type

10.1.1.3 Rest of South and Central America : South & Central America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Rest of South and Central America : South & Central America Infectious Disease Diagnostics Market Breakdown, by Product
10.1.1.3.2 Rest of South and Central America : South & Central America Infectious Disease Diagnostics Market Breakdown, by Technology
10.1.1.3.3 Rest of South and Central America : South & Central America Infectious Disease Diagnostics Market Breakdown, by Application Type

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. South & Central America Infectious Disease Diagnostics Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bruker Corp

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Cardinal Health Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 F. Hoffmann-La Roche Ltd

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Trinity Biotech Plc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Danaher Corp

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Bio-Rad Laboratories Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 ACON Laboratories Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 DiaSorin SpA

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights